| scholarly article | Q13442814 |
| P50 | author | James S O'Donnell | Q43228933 |
| Roger Preston | Q58710900 | ||
| P2093 | author name string | Eimear M Gleeson | |
| Orla Rawley | |||
| P2860 | cites work | Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII | Q24336195 |
| The Ashwell receptor mitigates the lethal coagulopathy of sepsis | Q24596452 | ||
| Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity | Q27640482 | ||
| Assembly of asparagine-linked oligosaccharides | Q28131690 | ||
| Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex | Q28201444 | ||
| LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway | Q28249792 | ||
| The cytoprotective protein C pathway | Q28274500 | ||
| Coagulation factor X interaction with macrophages through its N-glycans protects it from a rapid clearance | Q28484019 | ||
| Amino acid sequence of human von Willebrand factor | Q28630812 | ||
| Roles of N-linked glycans in the endoplasmic reticulum | Q29616458 | ||
| Glycosylation in cellular mechanisms of health and disease | Q29617310 | ||
| Analysis of the site-specific asparagine-linked glycosylation of recombinant human coagulation factor VIIa by glycosidase digestions, liquid chromatography, and mass spectrometry | Q32033263 | ||
| Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura | Q33339170 | ||
| Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands | Q33343091 | ||
| Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin | Q38337996 | ||
| A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi | Q38344795 | ||
| New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity | Q38346526 | ||
| Clotting factor concentrate switching and inhibitor development in hemophilia A. | Q39603925 | ||
| N-linked glycosylation of VWF modulates its interaction with ADAMTS13. | Q40059074 | ||
| Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1. | Q40117579 | ||
| In vivo clearance of human protein S in a mouse model: influence of C4b-binding protein and the Heerlen polymorphism. | Q40385334 | ||
| Amino acid distributions around O-linked glycosylation sites | Q41761661 | ||
| Glycosylation of tissue factor is not essential for its transport or functions | Q41893303 | ||
| Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5. | Q42133647 | ||
| A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor | Q42524319 | ||
| Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor | Q43086117 | ||
| Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13. | Q43228846 | ||
| Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications. | Q43763482 | ||
| An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. | Q44518932 | ||
| Primary structure of the major O-glycosidically linked carbohydrate unit of human von Willebrand factor | Q45196383 | ||
| Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo. | Q45261110 | ||
| Purification of recombinant human tissue factor. | Q45937551 | ||
| Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis | Q46484313 | ||
| O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions | Q47879767 | ||
| Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor level | Q60034607 | ||
| Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor | Q63354161 | ||
| Two residues in the activation peptide domain contribute to the half-life of factor X in vivo | Q63354278 | ||
| Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways | Q73259496 | ||
| Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis | Q75207795 | ||
| Coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome: case report and review of the literature | Q77779053 | ||
| The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs | Q84814859 | ||
| ??? | Q24564873 | ||
| Carbohydrates and activity of natural and recombinant tissue factor | Q33517083 | ||
| Posttranslational modifications and activity of natural and recombinant tissue factor | Q33729216 | ||
| Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation | Q33784627 | ||
| Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium | Q33817075 | ||
| Physiological variant of antithrombin-III lacks carbohydrate sidechain at Asn 135. | Q34185488 | ||
| In vivo analysis of the role of O-glycosylations of von Willebrand factor. | Q34278082 | ||
| Identification of O-linked oligosaccharide chains in the activation peptides of blood coagulation factor X. The role of the carbohydrate moieties in the activation of factor X. | Q34344830 | ||
| Mapping the N-glycome of human von Willebrand factor | Q34360160 | ||
| Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 kd protein | Q34369417 | ||
| Thrombin inhibition by antithrombin III on the subendothelium is explained by the isoform AT beta | Q34401769 | ||
| The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change | Q34428865 | ||
| Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells. | Q34488999 | ||
| Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation | Q34622020 | ||
| Differences in the fractional abundances of carbohydrates of natural and recombinant human tissue factor | Q34625347 | ||
| Concepts and principles of O-linked glycosylation | Q34749639 | ||
| A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes | Q35829158 | ||
| Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2 | Q35849432 | ||
| The COPII pathway and hematologic disease | Q36079805 | ||
| Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems | Q36410806 | ||
| ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? | Q36604393 | ||
| Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry | Q36885148 | ||
| The disappearing act of factor VIII. | Q37260659 | ||
| Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X. | Q37363970 | ||
| Functional roles of the factor VIII B domain | Q37497567 | ||
| Factor VIII and von Willebrand factor--too sweet for their own good | Q37768888 | ||
| Mechanisms and principles of N-linked protein glycosylation | Q37943105 | ||
| Diseases of glycosylation beyond classical congenital disorders of glycosylation | Q37985356 | ||
| Mammalian sialidases: physiological and pathological roles in cellular functions | Q37989368 | ||
| Carbohydrate clearance receptors in transfusion medicine | Q38030663 | ||
| Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity | Q38293560 | ||
| Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum | Q38295642 | ||
| A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells | Q38296274 | ||
| Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex. | Q38320989 | ||
| The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor | Q38325193 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3801-3810 | |
| P577 | publication date | 2013-02-20 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities | |
| P478 | volume | 121 |
| Q36788475 | A Quantitative Glycomics and Proteomics Combined Purification Strategy |
| Q38788396 | A conceptual and practical approach to haemostasis in paediatric liver disease. |
| Q45867572 | Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor |
| Q89777932 | Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells |
| Q47400963 | Coagulopathy in Zellweger spectrum disorders: a role for vitamin K. |
| Q91766531 | Deciphering the Roles of N-Glycans on Collagen-Platelet Interactions |
| Q36331236 | Definitive Screening Design Optimization of Mass Spectrometry Parameters for Sensitive Comparison of Filter and Solid Phase Extraction Purified, INLIGHT Plasma N-Glycans. |
| Q40975795 | Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM). |
| Q101038782 | Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor |
| Q104799811 | GlycoHunter: An Open-Source Software for the Detection and Relative Quantification of INLIGHT-Labeled N-Linked Glycans |
| Q28542564 | Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin |
| Q89934689 | Investigating the clearance of VWF A-domains using site-directed PEGylation and novel N-linked glycosylation |
| Q97551370 | Low VWF: insights into pathogenesis, diagnosis, and clinical management |
| Q45857947 | Measurement of factor IX activity in plasma-derived and recombinant concentrates: insights from thrombin generation and activation-based assays |
| Q39299024 | N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor. |
| Q35168028 | Role of the C-sheet in the maturation of N-glycans on antithrombin: functional relevance of pleiotropic mutations. |
| Q35824093 | Thrombin Generating Capacity and Phenotypic Association in ABO Blood Groups |
| Q43153236 | Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications |
Search more.